The 340B Debate | American Enterprise Institute
The 340B drug discount program has followed a familiar health policy trajectory. An intervention that was supposed to…
AI’s Uncertain Cost Effects in Health Care | American Enterprise Institute
The health care industry has a long history of below-average productivity gains, but there is cautious optimism that artificial…
Assessing privacy risks in the White House’s private health tracking system
On July 30, the White House announced a public-private partnership to build a digital health ecosystem that weaves…
A Closer Look at Direct Primary Care | American Enterprise Institute
As discussed in a recent Wall Street Journal opinion piece from Bobby Jindal and Charlie Katebi, the recently enacted GOP tax…
US drug supply chain exposure to China
Introduction Interest in the exposure of U.S. drug supply chains to China surged during the COVID-19 pandemic, as…
Pa. health leaders warn of impact from $180M liability case
Listen to this article Leaders from associations representing Pennsylvania health care providers and businesses are responding to a…